These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29370474)

  • 21. Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients.
    Sarafidis PA; Loutradis C; Karpetas A; Tzanis G; Piperidou A; Koutroumpas G; Raptis V; Syrgkanis C; Liakopoulos V; Efstratiadis G; London G; Zoccali C
    Hypertension; 2017 Jul; 70(1):148-157. PubMed ID: 28483919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension.
    Brandt MC; Reda S; Mahfoud F; Lenski M; Böhm M; Hoppe UC
    J Am Coll Cardiol; 2012 Nov; 60(19):1956-65. PubMed ID: 23062529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cuff-Based Oscillometric Central and Brachial Blood Pressures Obtained Through ABPM are Similarly Associated with Renal Organ Damage in Arterial Hypertension.
    Fernández-Llama P; Pareja J; Yun S; Vázquez S; Oliveras A; Armario P; Blanch P; Calero F; Sierra C; de la Sierra A
    Kidney Blood Press Res; 2017; 42(6):1068-1077. PubMed ID: 29197874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of blood pressure response: Obesity is associated with a less pronounced treatment response after renal denervation.
    Id D; Bertog SC; Ziegler AK; Hornung M; Hofmann I; Vaskelyte L; Matic P; Gafoor S; Sievert H
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):E30-8. PubMed ID: 26104216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact on Central Blood Pressure and Arterial Stiffness Post Renal Denervation in Patients With Stage 3 and 4 Chronic Kidney Disease: The Prairie Renal Denervation Study.
    Prasad B; St Onge JR; McCarron MCE; Goyal K; Dehghani P
    Can J Kidney Health Dis; 2017; 4():2054358117719028. PubMed ID: 28835849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal nerve ablation reduces augmentation index in patients with resistant hypertension.
    Hering D; Lambert EA; Marusic P; Ika-Sari C; Walton AS; Krum H; Sobotka PA; Mahfoud F; Böhm M; Lambert GW; Esler MD; Schlaich MP
    J Hypertens; 2013 Sep; 31(9):1893-900. PubMed ID: 23697964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial.
    Warchol-Celinska E; Prejbisz A; Kadziela J; Florczak E; Januszewicz M; Michalowska I; Dobrowolski P; Kabat M; Sliwinski P; Klisiewicz A; Topor-Madry R; Narkiewicz K; Somers VK; Sobotka PA; Witkowski A; Januszewicz A
    Hypertension; 2018 Aug; 72(2):381-390. PubMed ID: 29941516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study.
    Gosse P; Cremer A; Kirtane AJ; Lobo MD; Saxena M; Daemen J; Wang Y; Stegbauer J; Weber MA; Abraham J; Kario K; Bangalore S; Claude L; Liu Y; Azizi M
    Hypertension; 2021 Feb; 77(2):529-536. PubMed ID: 33356403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP; Papademetriou V; Dimitriadis KS; Kasiakogias A; Tsiachris D; Worthley MI; Sinhal AR; Chew DP; Meredith IT; Malaiapan Y; Thomopoulos C; Kallikazaros I; Tousoulis D; Worthley SG
    Int J Cardiol; 2015 Dec; 201():345-50. PubMed ID: 26301677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
    Lauder L; Ewen S; Tzafriri AR; Edelman ER; Cremers B; Kulenthiran S; Ukena C; Linz D; Kindermann I; Tsioufis C; Scheller B; Böhm M; Mahfoud F
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):845-851. PubMed ID: 29555535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal sympathetic denervation: early impact on ambulatory resistant hypertension.
    Schwerg M; Heupel C; Strajnic D; Baumann G; Laule M; Stangl V; Stangl K
    J Clin Hypertens (Greenwich); 2014 Jun; 16(6):406-11. PubMed ID: 24766570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative Blood Pressure Response to Upright Tilt Post Renal Denervation.
    Howden EJ; East C; Lawley JS; Stickford ASL; Verhees M; Fu Q; Levine BD
    Am J Hypertens; 2017 Jun; 30(6):632-641. PubMed ID: 28338768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The randomised Oslo study of renal denervation
    Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
    Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors for profound blood pressure response in patients undergoing renal sympathetic denervation.
    Fengler K; Rommel KP; Blazek S; von Roeder M; Besler C; Hartung P; Desch S; Thiele H; Lurz P
    J Hypertens; 2018 Jul; 36(7):1578-1584. PubMed ID: 29652730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of catheter ablation renal denervation in "mild" resistant hypertension.
    Chen S; Kiuchi MG; Acou WJ; Derndorfer M; Wang J; Li R; Kollias G; Martinek M; Kiuchi T; Pürerfellner H; Liu S
    J Clin Hypertens (Greenwich); 2017 Apr; 19(4):361-368. PubMed ID: 28266770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between renal sympathetic denervation and arterial stiffness: the ASORAS study.
    Zeijen VJM; Feyz L; Kardys I; Geleijnse ML; Van Mieghem NM; Zijlstra F; Lafeber M; Van Der Geest RJ; Hirsch A; Daemen J
    J Hypertens; 2023 Mar; 41(3):476-485. PubMed ID: 36655697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.
    Schmieder RE; Ott C; Schmid A; Friedrich S; Kistner I; Ditting T; Veelken R; Uder M; Toennes SW
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR; Gaehwiler R; Jaguszewski M; Sudano I; Osipova J; Schoenenberger-Berzins R; Erne P; Lüscher TF; Templin C
    Swiss Med Wkly; 2015; 145():w14102. PubMed ID: 25658048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.